Mana Therapeutics Funding: $35M Raised, Series A (2021)
Mana Therapeutics has raised $35M in total funding. Latest round: Series A. Backed by Cobro Ventures, Drew Dennison, LifeSci Venture Partners.
Mana Therapeutics funding overview
Mana Therapeutics has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for Mana Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Cobro Ventures, Drew Dennison, LifeSci Venture Partners. 3 distinct backers are named across the disclosed rounds.
Mana Therapeutics has raised $35M in total disclosed funding across the rounds on record.
Who has invested in Mana Therapeutics?
Cobro Ventures, Drew Dennison, LifeSci Venture Partners are named among the investors backing Mana Therapeutics.
What was the latest Mana Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2021.
Where is Mana Therapeutics based?
No headquarters location is disclosed for Mana Therapeutics.
When did Mana Therapeutics last raise?
The last disclosed Mana Therapeutics round closed in January 2021 at Series A.
Totals shown for Mana Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
